|
|
Picks Performance:
Outperforms
36%
of community
|
|
|
All-time Return
-5.63%
(in over 2 years)
|
Risk (SD)
Aggressive
0.00%
|
Sharpe Ratio
-21.65
|
Followers
135
|
Winning Picks
76
of
225
|
Total Views
150507
|
|
View:
Shared Picks (Quick)
/ (Detailed)
|
Personal Portfolio
September 04
This pick is about: Johnson Controls Inc. (JCI)
| Rating: |
$30.72 (09/04/08)
|
| Gain/Loss: |
-11.65%
in
446 days
|
|
|
|
|
September 02
This pick is about: Graham Corp (GHM)
| Rating: |
$74.45 (09/02/08)
|
| Gain/Loss: |
-73.66%
in
448 days
|
|
|
|
|
August 23
This pick is about: The Estee Lauder Companies Inc. (EL)
| Rating: |
$49.57 (08/23/08)
|
| Gain/Loss: |
-3.07%
in
458 days
|
|
|
|
|
August 22
This pick is about: Genoptix Inc. (GXDX)
| Rating: |
$34.24 (08/22/08)
|
| Gain/Loss: |
+8.70%
in
459 days
|
|
|
|
|
August 17
This pick is about: Morningstar Inc. (MORN)
| Rating: |
$64.66 (08/17/08)
|
| Gain/Loss: |
-25.95%
in
464 days
|
|
|
|
|
August 09
This pick is about: Quality Systems Inc. (QSII)
| Rating: |
$37.95 (08/09/08)
|
| Gain/Loss: |
+62.92%
in
472 days
|
|
|
|
|
This pick is about: Lufkin Industries Inc. (LUFK)
| Rating: |
$89.03 (08/09/08)
|
| Gain/Loss: |
-31.72%
in
472 days
|
|
|
|
|
August 06
This pick is about: Meridian Bioscience Inc (VIVO)
| Rating: |
$25.37 (08/06/08)
|
| Gain/Loss: |
-16.91%
in
475 days
|
|
|
|
|
This pick is about: ResMed Inc. (RMD)
| Rating: |
$43.09 (08/06/08)
|
| Gain/Loss: |
+17.13%
in
475 days
|
|
|
|
|
August 04
This pick is about: comScore Inc. (SCOR)
| Rating: |
$19.06 (08/04/08)
|
| Gain/Loss: |
-11.65%
in
477 days
|
|
|
|
|
July 13
This pick is about: Bitstream Inc. (BITS)
| Rating: |
$5.67 (07/13/08)
|
| Gain/Loss: |
+21.69%
in
499 days
|
|
|
|
|
July 03
This pick is about: Ecolab Inc. (ECL)
| Rating: |
$44.48 (07/03/08)
|
| Gain/Loss: |
+1.39%
in
509 days
|
|
|
|
|
June 25
This pick is about: VeraSun Energy Corp. (VSE)
| Rating: |
$4.11 (06/25/08)
|
| Gain/Loss: |
n/a
in
517 days
|
|
|
|
|
June 23
This pick is about: Fluor Corp. (FLR)
| Rating: |
$197.27 (06/23/08)
|
| Gain/Loss: |
-78.11%
in
519 days
|
|
|
|
|
June 09
This pick is about: ENSCO International Inc. (ESV)
| Rating: |
$77.98 (06/09/08)
|
| Gain/Loss: |
-42.14%
in
533 days
|
|
|
|
|
June 05
This pick is about: Greif Inc. (GEF)
| Rating: |
$68.92 (06/05/08)
|
| Gain/Loss: |
-17.79%
in
537 days
|
|
|
|
|
May 30
This pick is about: IHS Inc. (IHS)
| Rating: |
$58.93 (05/30/08)
|
| Gain/Loss: |
+10.83%
in
543 days
|
|
|
|
|
May 29
This pick is about: Copart Inc. (CPRT)
| Rating: |
$44.346 (05/29/08)
|
| Gain/Loss: |
-26.28%
in
544 days
|
|
|
|
|
May 23
This pick is about: Natus Medical Inc. (BABY)
| Rating: |
$21.23 (05/23/08)
|
| Gain/Loss: |
-33.58%
in
550 days
|
|
|
|
|
May 18
This pick is about: St Jude Medical Inc (STJ)
| Rating: |
$40.76 (05/18/08)
|
| Gain/Loss: |
-10.65%
in
555 days
|
|
|
|
|
September 02
This pick is about: Johnson Controls Inc. (JCI)
| Rating: |
$29.5 (09/02/08)
|
| Closed: |
09/04/2008
@ $30.72
(+4.14%
in
2 days)
|
|
|
|
|
February 26
"Looking Back One Year" A review of stock picks from the week of October 10, 2005
This pick is about: Johnson Controls Inc. (JCI)
| Rating: |
$32.17 (02/26/07)
|
| Closed: |
09/02/2008
@ $29.5
(-4.20%
in
554 days)
(+4.10%
from dividend)
|
|
|

Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice! As always, please remember that I am an amateur investor, so please remember to always consult with your professional investment advisers prior to making any investment decisions based on information on this website.
One of the jobs I like to do on weekends is to review past stock picks in as organized a fashion as possible. This "Weekend Review" started a couple of years ago, when I realized I needed to start examining past stock selections to find out how they all turned out. These reviews assume a "buy and hold" strategy. In practice, if you follow this blog on a regular basis, you will know that I employ my own idiosyncratic disciplined portfolio management system in which I sell my losing stocks quickly and completely and sell my gaining stocks slowly and partially at targeted appreciation levels.
But for the sake of this blog and the ease of reviewing past stock picks, I assume a strategy of buying equal $ amounts of each stock 'picked' and I assume I held onto those positions regardless of the price change. The difference between this strategy and what I actually employ and advocate in my blog would certainly affect actual performance.
During the week of October 10, 2005, I actually only 'picked' one stock for the blog, although I note that I had several discussions with readers about other stocks that week. Johnson Controls (JCI) is a stock that both my wife and my son have shares in, but I do not own any shares in my own "trading portfolio". This is one of my 'great Wisconsin firms' that I have written about on the blog. But of course I am proud of manufacturing companies from my adopted home state.
On October 12, 2005, I "revisited" Johnson Controls when the stock was trading at $63.60. I actually first wrote up Johnson Controls (JCI) on July 9, 2004, almost three years ago when the stock was trading at $53.24. Johnson Controls closed at $97.81 on February 23, 2007, for a gain of $34.21 or 53.8% since posting last year. More recently, I "revisited" Johnson Controls on Stock Picks Bob's Advice on December 20, 2006, when the stock was trading at $86.50.

On January 19, 2007, Johnson Controls (JCI) reported 1st quarter 2007 results. Sales for the quarter ended December 31, 2006, rose 9% to $8.2 billion from $7.5 billion in the prior year. However, net income dipped to $162 million or $.82/diluted share, down from $165 million or $.85/diluted share in the same period the prior year. No matter how much I like JCI, and no matter how well this stock has performed on this blog, the earnings report gets a 'thumbs-down' whenever it shows a decrease in either revenue or earnings on this blog.
So how did I do with this single stock pick from that week in October, 2005? Terrific! It showed an appreciation of 53.8% since posting in October, 2005.
|
|
August 01
This pick is about: Graham Corp (GHM)
| Rating: |
$101.75 (08/01/08)
|
| Closed: |
09/02/2008
@ $74.45
(-26.83%
in
32 days)
|
|
|
|
|
May 11
This pick is about: Morningstar Inc. (MORN)
| Rating: |
$73.88 (05/11/08)
|
| Closed: |
08/17/2008
@ $64.66
(-12.48%
in
98 days)
|
|
|
|
|
July 16
This pick is about: Lufkin Industries Inc. (LUFK)
| Rating: |
$90.97 (07/16/08)
|
| Closed: |
08/09/2008
@ $89.03
(-2.13%
in
24 days)
|
|
|
|
|
October 04
Quality Systems (QSII) and Immucor (BLUD)
This pick is about: Quality Systems Inc. (QSII)
| Rating: |
$38.81 (10/04/07)
|
| Closed: |
08/09/2008
@ $37.95
(-2.22%
in
310 days)
|
|
|
|
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. As I have written about previously, I am now being tracked by Covestor. You can visit my Covestor Page and note my own trading account performance. One of the uses of Covestor has been to help me identify the weaker stocks within my own portfolio. Quality Systems (QSII) has been one of my top performing stocks in my entire portfolio. However, it has been lagging as of late. There have been some 'clouds' around QSII that I have noted as an amateur investor reading the news stories on Yahoo. I didn't like the story about the Executive Vice President taking indeterminate leave for medical reasons. Previously on August 6, 2007, QSII reported 1st quarter results that missed expectations. The story isn't really over for QSII, I was just looking for something with a little bit more zip for my portfolio. While I am swapping out of QSII, I am thus reducing my rating for the stock: QUALITY SYSTEMS (QSII) IS RATED A HOLD Checking the list of top % gainers today, with an eye on something instead of QSII, I saw that Immucor (BLUD) a stock that I recently briefly reviewed , was acting well on the back of a solid 1st quarter earnings report that beat expectations. While not having a sale signal for my QSII, I sold my 88 shares of QSII at $38.70. These shares have been a terrific investment for me. I have sold my original shares of QSII multiple times (portions of my holding as it hit targeted appreciation prices over and over) and actually have a cost basis of $7.75 on them, purchased on 7/28/03. Thus, I had a gain of $30.95 or 399.4% since purchase! (How can I complain about that?) Since I was making a 'swap' on my own judgment, I purchased 154 shares of Immucor (BLUD) at $37.9499 shortly after my QSII sale. These sales and purchase are not strictly within my own trading rules. But since there appeared to be fundamental issues with QSII, and indeed the stock was lagging the rest of my portfolio, I decided it was a reasonable move. My only other stock at the present time that seems to be lagging is ResMed. However, ResMed, I believe, is involved in a temporary recall that is adversely affecting sales/profits. I will try to sit tight with that one for now. Thanks so much for stopping by and visiting my blog! If you have any comments or questions, please feel free to leave them on the blog or email me at bobsadviceforstocks@lycos.com. Bob
|
|
May 28
This pick is about: ResMed Inc. (RMD)
| Rating: |
$39.03 (05/28/08)
|
| Closed: |
08/06/2008
@ $43.09
(+10.40%
in
70 days)
|
|
|
|
|
August 03
This pick is about: comScore Inc. (SCOR)
| Rating: |
$19.1 (08/03/08)
|
| Closed: |
08/04/2008
@ $19.06
(-0.21%
in
15 hours)
|
|
|
|
|
July 16
This pick is about: Graham Corp (GHM)
| Rating: |
$89.8 (07/16/08)
|
| Closed: |
08/01/2008
@ $101.75
(+13.31%
in
16 days)
|
|
|
|
|
May 11
This pick is about: Meridian Bioscience Inc (VIVO)
| Rating: |
$28.23 (05/11/08)
|
| Closed: |
07/23/2008
@ $25.96
(-8.04%
in
73 days)
|
|
|
|
|
June 02
This pick is about: Graham Corp (GHM)
| Rating: |
$70.4899 (06/02/08)
|
| Closed: |
07/16/2008
@ $89.8
(+27.39%
in
44 days)
|
|
|
|
|
May 30
This pick is about: Visa Inc (V)
| Rating: |
$86.36 (05/30/08)
|
| Closed: |
06/11/2008
@ $77.74
(-9.98%
in
12 days)
|
|
|
|
|
January 17
Graham Corp (GHM)
This pick is about: Graham Corp (GHM)
| Rating: |
$37.6 (01/17/08)
|
| Closed: |
06/02/2008
@ $70.4899
(+87.47%
in
137 days)
|
|
|
|
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. Earlier today I found that my latest stock purchase, Graham Corp (GHM) had hit a sale point on the downside and I sold my 210 shares at $41.34. These shares had just been purchased on 1/10/08 at a price of $46.27. Thus, my loss on these shares worked out to $(4.93)/share or (10.7)% since purchase. My trading rules dictate me to implement sales as stocks hit (8)% losses. I am fairly 'old-fashioned' with these sales and monitor my stocks manually. With the fast-moving market, I probably should consider automatically setting up these transactions. Since this stock sale is on 'bad news', I do not have any permission to replace this investment with another holding. Thus, I am now down to 10 holdings in my trading account, down from my maximum of 20 and above my minimum of 5. My portfolio keeps 'talking to me' and I am listening. As is my practice, I shall be waiting for one of my positions to hit a sale at a targeted appreciation point to get that 'permission slip' to add another stock. Meanwhile, I am sitting on my hands. Hoping against hope that the market does not dictate another sale of a great company with a weak stock price. With this sale of my own shares, GRAHAM (GHM) IS RATED A HOLD Thanks so much for visiting! If you have any comments or questions, please feel free to leave them right on the website or email me at bobsadviceforstocks@lycos.com. Bob
|
|
May 11
This pick is about: IHS Inc. (IHS)
| Rating: |
$67.25 (05/11/08)
|
| Closed: |
05/30/2008
@ $58.93
(-12.37%
in
19 days)
|
|
|
|
|
This pick is about: Copart Inc. (CPRT)
| Rating: |
$41.64 (05/11/08)
|
| Closed: |
05/29/2008
@ $44.346
(+6.50%
in
18 days)
|
|
|
|
|
This pick is about: ResMed Inc. (RMD)
| Rating: |
$40.33 (05/11/08)
|
| Closed: |
05/28/2008
@ $39.03
(-3.22%
in
17 days)
|
|
|
|
|
February 15
Chase Corporation (CCF)
This pick is about: Chase Corp (CCF)
| Rating: |
$15.23 (02/15/07)
|
| Closed: |
05/14/2008
@ $18.77
(+23.24%
in
454 days)
|
|
|
|
I was looking through the lists of top % gainers and came across a name on the AMEX gainers list that made the list a couple of days ago as well--Chase Corporation (CCF). Chase closed today at $33.49, up $1.24 or 3.84% on the day. I do not own any shares or options on this stock.
I believe this company deserves a spot on the blog for numerous reasons. Let's take a closer look at some of the supporting information for this stock and I believe I can convince you as well!...
...Well, as you know, I wouldn't be writing up this stock unless I liked it! However, reviewing some of the above, the company is moving strongly higher the past few days, the last quarter was spectacular with growth in revenue and earnings. With the earnings increasing by about 150% over last year's results! And the p/e of the stock is in the teens. On top of this, the company has been reporting solid revenue growth the past five years at least, earnings have been growing nicely the last 3-4 years, and they even pay a dividend which they have been boosting.
|
|
September 27
Copart (CPRT)
This pick is about: Copart Inc. (CPRT)
| Rating: |
$33.85 (09/27/07)
|
| Closed: |
05/11/2008
@ $41.64
(+23.01%
in
227 days)
|
|
|
|
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. After selling my Starbucks (SBUX) stock earlier today on my own discretion, I chose to use this as an opportunity to replace that position with something with a bit more exciting prospects (?), or pizzazz as I wrote. Looking through the list of top % gainers , I came across an old favorite of mine Copart (CPRT) which I had discussed as far back as May 26, 2004 on Stock Picks Bob's Advice, making a nice move higher. As I write, Copart is trading at $33.51, up $3.53 or 11.78% on the day. This morning Copart reported strong fiscal 4th quarter results that beat expectations. Except for a dip in earnings in 2006, their Morningstar.com "5-Yr Restated" financials is intact, and their StockCharts.com "point and figure" chart looks strong. Thus, COPART (CPRT) IS RATED A BUY A few moments ago I purchased 210 shares of Copart (CPRT) for my Trading account at a price of $33.6757. Wish me luck! Thanks again for stopping by and visiting. If I get a chance, I shall try to write up a more complete update on Copart, but the above links should give you any needed additional information. If you have any comments or questions, please feel free to leave them on the blog or email me at bobsadviceforstocks@lycos.com. Bob
|
Update 10/01:
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any decisions based on information on this website. Last Thursday I reported on my purchase of shares of Copart (CPRT) and promised I would try to get a bit more of a review on the blog than the brief comments after the purchase. As I reported in that entry, I do own shares and infact purchased 210 shares on 9/27/07 at a price of $33.68. Copart is not a new name for me. In fact, I wrote up Copart on 5/26/04 when the stock was trading at $23.02. Copart (CPRT) closed at $34.39 on 9/28/07, for a gain of $11.37 or 49.4% since posting this stock three years ago.
Let me go through some of the data underlying my decision to purchase shares and explain why COPART (CPRT) IS RATED A BUY What exactly does this company do? According to the Yahoo "Profile" on CPRT, the company "...provides salvage vehicle sale services primarily in the United States. It offers vehicle suppliers, primarily insurance companies, with a range of services to process and sell salvage vehicles over the Internet through its virtual bidding Internet auction-style sales technology."
How did they do in the latest quarter? On September 26, 2007, after the close of trading, Copart announced 4th quarter 2007 results. Revenue for the quarter ended July 31, 2007, came in at $154.0 million, up 12.2% from last year's results. Income came in at $36.7 million or $.40/diluted share up 21.2% from last year's result of $31.6 million or $.35/share. Analysts according to Thomson Financial had expected profit of $.35/share on revenue of $138.1 million. Thus the company handily beat expectations.
How about longer-term results? Reviewing the Morningstar.com "5-Yr Restated" financials on CPRT, we can see the steady increase in revenue from $306.5 million in 2002 to $528.6 million in 2006 and $547.8 million in the trailing twelve months (TTM). Except for a dip in 2006 to $1.00 from $1.10/share, earnings have been growing nicely since 2003 when the company earned $.60/share. The latest twelve months shows Copart with earnings of $1.40/share. No dividend is paid but the shares outstanding are stable with 89 million reported in 2002 increasing only to 90 million in the TTM. Free cash flow is positive with $70 million in 2005, $45 million in 2006 and $84 million in the TTM. The balance sheet from Morningstar appears very strong, with $124 million in cash which by itself could easily pay off both the $80.7 million in current liabilities and the $1.5 million in long-term liabilities combined.
What about some valuation numbers? Using the numbers from Yahoo "Key Statistics" on Copart, we find that the company is a mid cap stock with a market capitalization of $3.04 billion. The trailing p/e is a moderate 23.57 with a forward p/e (fye 31-Jul-09) estimated at 17.91. Estimating the earnings going forward over the next five years, the PEG works out to an acceptable 1.42. According to the Fidelity.com eresearch website, Copart has a Price/Sales (TTM) ratio of 5.54, much higher than the average in the industry of 2.35. On a positive note, the company is reported to be somewhat more profitable than average, with a Return on Equity (TTM) of 15.40%, higher than the industry average of 13.09%. Finishing up with Yahoo, we find that there are 88.33 million shares outstanding with 69.21 million that float. As of 9/11/07, there were 1.02 million shares out short, representing 1.4% of the float or 4 trading days of volume. This is slightly higher than my own 3 day rule for short interest. No dividends are paid and the last stock split reported on Yahoo was a 3:2 stock split on January 22, 2002.
What does the chart look like? Reviewing the "Point & Figure" chart on CPRT from StockCharts.com, we can see the weakness in the price chart through much of 2002 as it dipped from $25/share in January, 2002, to a low of $7.00 in March, 2003. Since that time, the stock has been moving steadily higher . The chart does not appear particularly 'overexteded' to me.

Summary: What do I think? Well I like this stock! In almost a 'recession play', the stock fills a niche for automobiles and is involved in car auctions. I am confident that in any weakness in the economy, more and more car purchasers are looking at used cars...of courst that is only my speculation. Earnings were great as the company handily beat expectations. Valuation isn't bad with a moderate p/e and a PEG under 1.5. The Price/Sales is a bit rich but the Return on Equity was a bit better than average. Finally, the stock chart looks nice.
Thanks so much for stopping by and visiting. If you have any comments or questions, please feel free to leave them on the blog or email me at bobsadviceforstocks@lycos.com. If you can, be sure and visit my Stock Picks Podcast site, my Covestor Page where my trading portfolio is analyzed, and my SocialPicks page where all of my stock picks from early 2007 are stored. Have a great week trading! Bob
|
|
July 09
Trading Portfolio Update July 8, 2007
This pick is about: ResMed Inc. (RMD)
| Rating: |
$41.93 (07/09/07)
|
| Closed: |
05/11/2008
@ $40.33
(-3.82%
in
307 days)
|
|
|
As I like to do from time to time on this blog, I would like to share with you the current status of my Trading Portfolio. I last wrote up my "trading portfolio update" on June 7, 2007 , a month ago. There have been a few changes since then. But the biggest development has been my partipation in Covestor. You now can check my Covestor page and see the daily changes, all trades, and my performance relative to the indices and other registered investors. Thus far, I have been doing quite well as it has been a fortunate month for me especially with he Ventana bid by Roche . I am always grateful when my portfolio and my investing strategy is woking; but I am aware that there will be times when nothing seems to work. Sometimes the most successful approach is about persistence and patience. This past month also found me shaken-out of Gildan Activewear , which seemed to almost know I had sold on a dip and gleefully turned around to move higher making the top % gainers list that same day! O.K. that's a bit too anthropomorphic, but still, don't you just hate those days sometimes :). So I am back to 19 positions. Let's take a look at them and I will share with you in order: the symbol, number of shares, date of purchase, price of purchase, latest price (7/6/07), and percentage gain (or loss). ResMed (RMD), 150 shares, 2/4/05, $29.87, $41.72, 39.68% Since my last review on June 7, 2007, I sold 23 shares of Ventana at $76.83, and the rest of the 139 shares of Ventana (VMSI) at $76.502 later the same day on 6/26/07. On that day I purchased 350 shares of MEDTOX at $28.5534, Bolt hit another appreciation target and I sold 1/7th of my holding (21 shares) at $50.52. Finally, on 7/5/07, I sold my 210 shares of Gildan at $33.1101 when it hit an (8)% loss after purchase. Currently I am at 19 positions. My equity value is $119,962.09, my margin balance is at $56,031.51, giving me a 53.29% margin equity percentage. As of 7/6/07, I have $33,571.01 in unrealized gains in my account, and with the above trades have taken $3,100.15 in net short-term gains, and $17,824.18 in net long-term gains for a total of $20,924.33 in realized gains for 2007. I also have paid $2,563.07 in margin interest and have received a total of $272.58 in ordinary dividends and distributions and miscellaneous income.
|
Update 03/02:

Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. With the market correction ongoing, my portfolio has been reduced in size (as it is supposed to!) down to seven positions. As is my practice, I have been trying to share with you my performance on the actual stocks that I own in addition to the many stocks I write about on this blog. My last review was Morningstar (MORN), a holding that I discussed on January 19, 2008. Going alphabetically (by symbol) I am up to my ResMed position. I currently own 150 shares of ResMed (RMD) that were acquired on 2/4/05 at a cost basis of $29.87. ResMed closed at $40.49 on 2/29/08 for an unrealized gain of $10.62 or 35.5% on these shares.
ResMed is an old favorite of mine, having first reviewed the stock (before owning the shares) back on December 5, 2003, when the stock was trading at $41.76. Adjusted for the 2:1 stock split on October 3, 2005, this works out to a pick price of $20.88. The stock has actually appreciated $19.61 or 94% since that original posting. As is my practice, I have sold portions of my ResMed position twice as they hit appreciation targets of 30% and 60% over the purchase price. I sold shares 9/27/05 at a split-adjusted price of $38.82, representing a gain of $8.95 or 30.0%, and another batch of shares at $47.47 on 5/5/06, representing a gain of $17.60 or 59.0% since purchase. When would I sell shares next? Well, on the downside it has been my policy to sell shares if they retrace back to 1/2 of the highest percentage at which I have sold shares (if I have sold more than once). In this case, with the highest % sale at the 60% appreciation level, I plan on selling all of my shares should ResMed trace back to the 30% appreciation level (which it has been flirting with several times already). This would work out to 1.3 x $29.87 = $38.83. On the other hand, if the stock should move higher, the next targeted sale in my 'system' is at the 90% appreciation level at which time I would plan on selling 1/7th of my remaining shares. This works out to 150 x 1/7 = 21 shares, which would be sold should the stock reach 1.9 x $29.87 = $56.75. Unfortunately, the stock is far closer to the sale on the downside rather than the sale on appreciation. Time will tell.
Let's take a closer look at this company and decide how we should rate this stock for the blog! First of all, What exactly does this company do? According to the Yahoo "Profile" on ResMed, the company
"...engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of -disordered breathing, including obstructive sleep apnea, and other respiratory disorders that occur during sleep. It offers airflow generators, diagnostic products, mask systems, headgear, and other accessories, including humidifiers, cold passover humidifiers, carry bags, and breathing circuits."
How did they do in the latest quarter? On February 8, 2008, ResMed (RMD) reported 2nd quarter 2008 results. For the quarter ended December 31, 2007, revenue increased 14% to $202.7 million from $178.4 million a year earlier. This exceeded estimates of $183.8 million. Earnings dipped to $26.9 million or $.34/share this year compared to last year's $29 million or $.37/share. However, removing one-time stock-based compensation costs and restructuring charges and other one-time items, profit came in at $32.1 million or $.41/share, down from $33.7 million last year. However, the $.41/share figure exceeded estimates of $.35/share according to analysts polled by Thomson Financial.
How about longer-term results? Reviewing the Morningstar.com "5-Yr Restated" financials page, we can see a little bit of a mix of results. Revenue growth has been particularly stable with $274 million in 2003 increasing to $716 million in 2007 and $763 million in the trailing twelve months (TTM). Earnings had a steady growth record from 2003 to 2006 when they increased from $.67/share in 2003 to $1.16/share in 2006. Earnings however dipped to $.85/share in 2007 and $.81/share in the TTM. These results of course exclude 'one-time' events. But they should be respected. Free cash flow has improved after dipping from $31 million in 2005 to a negative $(4) million in 2006, improving to $14 million in 2007 and $22 million in the TTM. The balance sheet is solid with $279.0 million in cash and $411.0 million in other current assets. This total of $690 million, when compared to the $162.7 million in current liabilities yields a current ratio of 4.24. (I use a level of 1.25 on the current ratio as a minimum to consider the balance sheet 'healthy'.) RMD has a relatively small level of long-term liabilities at $142.0 million.
What about some valuation numbers? Examining the Yahoo "Key Statistics" on ResMed (RMD), we can see that this is a mid cap stock with a market capitalization of $3.15 billion. The trailing p/e is rather rich at 50.24, the forward p/e (fye 30-Jun-09) is estimated at 21.77 and with the rapid growth in earnings expected, the PEG ratio works out to an acceptable level of 1.46. Utilizing the Fidelity.com eresearch website, we find that the Price/Sales (TTM) is reasonably priced at less than its peers at 4.12, compared to an industry average of 4.91. The company is not as profitable as its peers per Fidelity with a Return on Equity (TTM) of 6.66% compared to the industry average of 20.68%. Finishing up with Yahoo, we find that there are 77.68 million shares outstanding with 75.14 million that float. As of 1/10/08, there were 5.85 million shares out short, well above my 3 day rule of significance, with the short ratio working out to 8.1 days of trading volume. No dividends are paid and the last stock split was a 2:1 paid on October 3, 2005.
What does the chart look like? Reviewing the 'point & figure' chart on ResMed from StockCharts.com, we can see the strong price appreciation from August, 2002, when the stock was trading at $13.00/share, to a peak of $56 in February, 2007. The stock broke through support on the downside in August, 2007, when it dipped below $42. The stock has been struggling technically (from my amateur perspective) and once again broke through support at $42 this month. Short-term, the chart looks weak without showing a complete break-down in support.

Summary: What do I think?
I really am very biased about this stock. I think there are loads of people out there with sleep apnea and Resmed has a great product and great future. THAT is my 'Peter Lynch' portion of this stock pick. I have some concerns about the latest quarter with all sorts of one-time charges needing to be sorted out to get to a result that still shows a decline year-over-year. And this has been going on for at least a year as the Morningstar.com report suggests. Furthermore, valuation is a bit rich with a p/e over 50 (although I can live with the PEG). The Price/Sales suggests a reasonable valuation, but the Return on Equity suggests that profitability might be lagging. The rest of the Morningstar report is solid. However, the chart also gives me pause. What this company really needs is a blow-out quarter!
Anyhow, even though I own shares, the best I can come up with is... RESMED (RMD) IS RATED A HOLD Thanks again for stopping by and visiting my blog! If you have any comments or questions, please feel free to leave them right on the website or email me at bobsadviceforstocks@lycos.com. If you get a chance, be sure and stop by my Covestor Page where you can see how my Trading Portfolio is doing relative to the S&P and other investors, my SocialPicks page where my stock picks from the last year or two are reviewed and analyzed, and my Podcast Page where you can download a show or two about some of the many stocks I write about here on the website! Wishing you a happy weekend and a successful week ahead trading! Yours in investing, Bob
|
|
December 23
IHS Inc (IHS)
This pick is about: IHS Inc. (IHS)
| Rating: |
$63.95 (12/23/07)
|
| Closed: |
05/11/2008
@ $67.25
(+5.16%
in
140 days)
|
|
|
|
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. As part of my continued effort at transparency on this website, I have been reviewing my actual holdings in my Trading Account approximately every three weekends. Currently with 13 positions, this will take me about 39 weeks to complete the cycle. Three weeks ago I reviewed Harris Corporation . Going alphabetically (by symbol) brings me up to IHS Corp (IHS). Let's take a closer look at this stock and see whether it still deserves a spot on my blog and in my own investment portfolio. Currently I own 140 shares of IHS which closed at $64.20 on December 21, 2007. These shares were acquired 10/1/07 with a cost basis of $58.53, giving me an unrealized gain of $5.67 or 9.7% since purchase. This is actually the second time that I have owned IHS. I purchased shares 3/22/07, only to see them decline to a sale point 4/9/07 at which time those shares were sold resulting in a $(465.98) loss in a couple of weeks time. I am occasionally asked about whether I will 'revisit' a stock after having solid it at a loss. I think that IHS demonstrates that I do keep these stocks on my investing 'horizon' even if they are sold on what I would call a 'technical' basis. I first discussed IHS on this blog on March 24, 2007 , when the stock was trading at $42.10. What exactly does this company do? According to the Yahoo "Profile" on IHS , the company "...provides technical information, decision-support tools, and related services to customers in the energy, defense, aerospace, construction, electronics, and automotive industries worldwide. It operates in two segments: Energy and Engineering. The Energy segment develops and delivers oil and gas industry data on exploration, development, production, and transportation activities to energy producers and oil companies. It also provides decision-support tools and operational, research, and strategic advisory services to these customers, as well as to utilities and transportation, petrochemical, coal, and power companies. The Engineering segment provides solutions, such as technical specifications and standards, regulations, parts data, design guides, and other information to customers in its targeted industries. This segment serves defense, aerospace, construction, energy, electronics, and automotive industries. The company' customers range includes governments, multinational corporations, smaller companies, and technical professionals." How did they do in the latest quarter? On September 20, 2007, IHS reported 3rd quarter 2007 results . Revenue for the quarter ended August 31, 2007, came in at $183.4 million, up 31% over the 3rd quarter 2006 results of $139.9 million. Net income increased similarly to $21.7 million from $16.1 million and earnings grew 25% to $.35/share from $.28/diluted share last year. How about longer-term results? Examining the Morningstar.com "5-Yr Restated" financials on IHS, we can see the steady revenue growth from $339 million in 2002 to $551 million in 2006 and $639 million in the TTM. Earnings have been a bit more erratic with results climbing to $1.11/share in 2004 before dipping to $.75/share in 2005, but resuming the climb to $.99/share in 2006 and $1.22/share in the TTM. No dividends are paid. Outstanding shares are stable with 69 million in 2003 increasing only slightly to 71 million in the TTM. Free cash flow is positive and growing with $63 million in 2004 and $105 million in 2006 and $101 million in the TTM. The balance sheet is just adequate with $132 million in cash and $221 million in other current assets compared to the current liabilities of $350.9 million. This works out to a current ratio of 1.01. I would prefer to see companies with more current assets and ratios of at least 1.25. There are $86.2 million in long-term liabilities as well. What about some valuation numbers? Looking at Yahoo "Key Statistics" on IHS , we can see that this company is a mid cap stock with a market capitalization of $4.02 billion. The trailing p/e is rich at 52.28 with a forward p/e of 33.61 (fye 30-Nov-08). According to Yahoo, the p/e is not justified in terms of anticipated growth as the PEG ratio (5 yr expected) comes in a bit rich at 1.90. This richness in valuation is reflected as well, using Fidelity information, by the Price/Sales ratio which is 5.99 is well above the industry average of 2.40. In terms of profitability, as measured by the Return on Equity (TTM) statistic, we find that IHS does a little better with a statistic of 11.38 vs. the industry average of 8.73%. Yahoo reports 62.65 million shares outstanding with 58.13 million shares that float. There are 2.02 million shares out short as of 11/9/07. This is moderately significant as it totals 7 trading days of volume (the short ratio) to cover. No stock dividends are reported on Yahoo and no cash dividends have been paid. What does the chart look like? Examining the "point & figure" chart from StockCharts.com on IHS, we can see that this stock has steadily appreciated from November, 2005, when the stock was trading at $17 to a peak of $72/share in December, 2006. The stock has pulled back somewhat but overall the sharp and steady ascent appears intact. When would I sell these shares? With a cost basis of $58.53, and not having sold any shares of this lot yet, I would sell all my shares should the stock decline to an 8% loss which works out to .92 x $58.53 = $53.85. On the upside, my plan is to sell 1/7th of my shares or 20 shares at the 30% appreciation target. This works out to 1.3 x $58.53 = $76.09. Summary: What do I think about IHS? I like IHS and continue to own the stock. That being said, I have concerned about the p/e in the 50's, a PEG over 1.5, and a price/sales ratio double the stock in its industry. I do not see any analysts on this stock and don't know whether the latest quarter was above or below 'street' expectations. The graph shows upward price momentum but appears to be a bit over-extended. In addition, the balance sheet shows relatively heavy current debt loads with a current ratio barely over 1.0. Thus, IHS (IHS) IS RATED A HOLD Thanks again for stopping by and visiting. If you have any comments or questions, please feel free to leave them on the blog or email me at bobsadviceforstocks@lycos.com. If you get a chance, be sure and visit my Covestor Page , my SocialPicks Page , and my Podcast Website . Have a great shortened week and wishing all of my friends a very Merry Christmas and a wonderful New Year! Bob
|
|
|
|
|
You need to log in to see how similar Robert Freedland is
to you in terms of investment style, risk profile, and other metrics.
Compare Your Portfolio With Robert Freedland:
Enter stocks you like & get new ideas daily:
Symbols, separated by space (e.g. AAPL GOOG MSFT)
More about Robert Freedland
Investment Style:
Moderate
[?]
More willing to take occasional risks while protecting assets from the risk of major losses. Portfolio is comprised mostly of solid companies with a history of consistently creating returns for investors, but includes some riskier holdings such as smallcaps, or foreign companies that will posses larger returns.
Avg exp holding time:
534.04 days
|
Age:
50's
|
Occupation:
Amateur Investor
|
|
Location:
Wisconsin
|
Website:
bobsadviceforstocks.tripod.com/bobsadviceforstocks..
About Me:

I am a physician who also enjoys examining investments for possible appreciation. I have been inv
... more

I am a physician who also enjoys examining investments for possible appreciation. I have been investing in the stock market since the age of 13 in 1967 and am currently in my 40th year of following the market as an amateur investor. Having examined many investment strategies, I have settled on my own disciplined approach drawing from the CANSLIM technique of William O'Neil and searching for the finest companies in America as Gene Walden wrote in "100 Best Stocks to Own in America". Like Robert Lichello, in 'How to Make $1,000,0000 in the Stock Market--Automatically", I am searching for a way to allow my own portfolio to dictate my own trading actions. I have been blogging on Stock Picks Bob's Advice since May, 2003, and have written up over 1,400 entries on my blog about various stocks, my own trading account, and investment strategy.
|
|